✦ LIBER ✦

Preliminary experiences using the MGuard stent platform in saphenous vein graft lesions

✍ Scribed by Hana Vaknin-Assa; Abid Assali; Ran Kornowski

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 115 KB
Volume: 74
Category: Article
ISSN: 1522-1946
DOI: 10.1002/ccd.22075

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Distal embolization after net protective

Distal embolization after net protective stent (MGUARD™) implantation in a degenerated saphenous vein graft lesion

✍ Ihab Yassin; Leif Thuesen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

Contemporary use of embolic protection d

Contemporary use of embolic protection devices in saphenous vein graft interventions: Insights from the stent of saphenous vein grafts trial

✍ Richard R. Heuser 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 29 KB 👁 2 views

Contemporary use of embolic protection d

Contemporary use of embolic protection devices in saphenous vein graft interventions: Insights from the stenting of saphenous vein grafts trial

✍ Neeraj Badhey; Christopher Lichtenwalter; James A. de Lemos; Michele Roesle; Owe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 2 views

Long-term clinical outcomes of real-worl

Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease

✍ Ravi K. Ramana; Adam Ronan; Kevin Cohoon; David Homan; Jessica Sutherland; Lowel 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

## Abstract Objective: To evaluate the long‐term clinical outcomes of patients undergoing percutaneous coronary intervention for saphenous vein graft (SVG) disease. Specifically, we compared clinical endpoints of patients who received sirolimus‐eluting stents (SES) versus bare‐metal stents (BMS) fo

Feasibility, safety, and preliminary eff

Feasibility, safety, and preliminary efficacy of a novel ePTFE-covered self-expanding stent in saphenous vein graft lesions: The Symbiot II trial

✍ Gerrit J. Laarman; Ferdinand Kiemeneij; Ralf Mueller; Giuglio Guagliumi; Michael 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB 👁 2 views

Lack of clinical long-term benefit with

Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts

✍ Giuseppe Gioia; Alberto Benassi; Raghar Mohendra; Khaza Chowdhury; Iqbal Masood; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 2 views

## Abstract Background: Small randomized trials have shown short‐term improved outcome with drug‐eluting stents (DES) over bare metal stent (BMS) in saphenous vein graft (SVG) interventions by reducing in‐stent restenosis and target vessel revascularization (TVR). It is not clear, however, if these